The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma

被引:20
|
作者
Albonico, Francesca [1 ]
Mortarino, Michele [1 ]
Avallone, Giancarlo [1 ]
Gioia, Gloria [1 ]
Comazzi, Stefano [1 ]
Roccabianca, Paola [1 ]
机构
[1] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, I-20133 Milan, Italy
关键词
MicroRNA; Dog; Splenic lymphoma; FFPE; Grading; RT-qPCR; MICRORNA EXPRESSION; MALIGNANT-LYMPHOMAS; CLASSIFICATION; IDENTIFICATION; BLADDER; GENES; DOGS;
D O I
10.1016/j.vetimm.2013.06.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In dogs as in humans, microRNAs (miRNAs) play a key role in normal and neoplastic hematopoiesis regulation. The general miRNA expression framework varies among different stages of development and differentiation of tumors, and miRNAs are widely investigated as new molecular tools for cancer diagnosis and classification. Canine lymphomas are currently classified according with the WHO classification, but a comprehensive grading study of clinical samples is still lacking, and molecular tools for quick grading are not yet available. In the present work, a retrospective study of the expression profile of a panel of miRNAs in canine primary splenic lymphomas was performed. The formalin fixed, paraffin embedded (FFPE) lymphoma samples were accurately classified according with the WHO classification, and were analyzed for miRNA expression using stem-loop TaqMan real time RT-PCR. For each miRNA investigated, relative and absolute quantification were performed after selecting the best housekeeping genes using the NormFinder and geNorm algorithms. The results of this study show a diversity in miRNA expression in low (L) grade lymphomas compared to intermediate-high (I-H) grade lymphomas. The molar ratio between miR-17-5p and miR-155 correlated with WHO grading. These results highlight the potential use of miR-17-5p/miR-155 molar ratio as a new molecular tool for grading of canine splenic lymphomas. The data here reported further support the utility of monitoring miRNA expression in canine hematopoietic malignancies diagnosis and prognosis. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:117 / 123
页数:7
相关论文
共 50 条
  • [41] Differential Expression of miR-155 and miR-21 in Tumor and Stroma Cells in Diffuse Large B-Cell Lymphoma
    Munch-Petersen, Helga D.
    Ralfkiaer, Ulrik
    Sjo, Lene D.
    Hother, Christoffer
    Asmar, Fazila
    Nielsen, Boye S.
    Brown, Peter
    Ralfkiaer, Elisabeth
    Gronbaek, Kirsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (03) : 188 - 195
  • [42] LOW EXPRESSION OF MIR-155 IN VINCRISTINE RESISTANT DIFFUSE LARGE B-CELL LYMPHOMA
    Due, H.
    Schonherz, A. Amanda
    Krogh, L. Bechmann
    Bodker, J. Stove
    Schmitz, A.
    Brondum, R. Froberg
    Johnsen, H. Erik
    Bogsted, M.
    Mikkelsen, J. Giehm
    Roug, A. Stidsholt
    Dybkaer, K.
    HAEMATOLOGICA, 2016, 101 : 398 - 398
  • [43] Expression of miR-17-5p in the plasma of patients with multiple myeloma and its role in tumorigenesis and development
    向谱
    ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (04) : 228 - 229
  • [44] High Expression of Serum miR-17-5p Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
    Zheng, Jianjian
    Dong, Peihong
    Gao, Shenmeng
    Wang, Ni
    Yu, Fujun
    HEPATO-GASTROENTEROLOGY, 2013, 60 (123) : 549 - 552
  • [45] Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92
    H Matsubara
    T Takeuchi
    E Nishikawa
    K Yanagisawa
    Y Hayashita
    H Ebi
    H Yamada
    M Suzuki
    M Nagino
    Y Nimura
    H Osada
    T Takahashi
    Oncogene, 2007, 26 : 6099 - 6105
  • [46] Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
    Xu, Jie
    Meng, Qingtao
    Li, Xiaobo
    Yang, Hongbao
    Xu, Jin
    Gao, Na
    Sun, Hao
    Wu, Shenshen
    Familiari, Giuseppe
    Relucenti, Michela
    Zhu, Haitao
    Wu, Jiong
    Chen, Rui
    CANCER RESEARCH, 2019, 79 (19) : 4882 - 4895
  • [47] Prognostic value of miR-17-5p in cancers: a meta-analysis
    Kong, Weihao
    Cheng, Yusheng
    Liang, Hao
    Chen, Qiangxing
    Xiao, Cuicui
    Li, Kun
    Huang, Zenan
    Zhang, Jian
    ONCOTARGETS AND THERAPY, 2018, 11 : 3541 - 3549
  • [48] Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92
    Matsubara, H.
    Takeuchi, T.
    Nishikawa, E.
    Yanagisawa, K.
    Hayashita, Y.
    Ebi, H.
    Yamada, H.
    Suzuki, M.
    Nagino, M.
    Nimura, Y.
    Osada, H.
    Takahashi, T.
    ONCOGENE, 2007, 26 (41) : 6099 - 6105
  • [49] Circulating miR-17-5p as a potential biomarker for diagnosis and prognosis in osteosarcoma
    Zhu, Hongxuan
    Liao, Qiande
    Yin, Ke
    Zhong, Da
    Wang, Chenggong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3409 - 3416
  • [50] Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori Eradication (Publication with Expression of Concern)
    Saito, Yoshimasa
    Suzuki, Hidekazu
    Tsugawa, Hitoshi
    Imaeda, Hiroyuki
    Matsuzaki, Juntaro
    Hirata, Kenro
    Hosoe, Naoki
    Nakamura, Masahiko
    Mukai, Makio
    Saito, Hidetsugu
    Hibi, Toshifumi
    PLOS ONE, 2012, 7 (11):